期刊文献+

人IL-8正义和反义真核表达载体的构建与表达

Construction and expression of human IL-8 sense or antisense eukaryotic expression vectors
下载PDF
导出
摘要 目的:构建人IL-8正义和反义真核表达载体。方法:RT-PCR扩增正义和反义IL-8基因片段后,将其克隆入真核表达载体pcDNA3.1(+),通过菌落PCR、双酶切及测序进行鉴定后,采用脂质体法分别瞬时转染至人卵巢癌细胞系A2780和SKOV3细胞中,并用RT-PCR和ELISA法检测细胞转染后IL-8的表达水平。结果:经验证,重组人IL-8正义/反义真核表达载体构建正确。pcDNA3.1(+)-ssIL-8转染A2780细胞后,其IL-8 mRNA及蛋白表达水平均显著增加;而pcDNA3.1(+)-asIL-8转染SKOV3细胞后,其IL-8分泌水平降低。结论:成功构建了人IL-8正义/反义真核表达质粒pcDNA3.1(+)-ssIL-8/pcDNA3.1(+)-asIL-8,为后续研究IL-8在卵巢癌及其他肿瘤中的作用打下基础。 AIM:To construct the sense or antisense IL-8 eukaryotic expression vectors. METHODS:Sense or antisense IL-8 full length gene were amplified by RT-PCR and cloned into eukaryotic expression vector pcDNA3.1(+). After the identification by PCR,restriction endonuclease digestion and the nucleotide sequencing,the recombinant vectors were transfected into human ovarian carcinoma A2780 and SKOV3 cell lines transiently by lipofectamine mediation. The expression of IL-8 gene and protein were detected by RT-PCR and ELISA. RESULTS: The sense or antisense IL-8 eukaryotic expression vectors were constructed and verified. The expression of IL-8 gene and protein in A2780 cells transfected with pcDNA3, 1 ( + )-sslL-8 were increased, whereas the expression of IL-8 protein in SKOV3 cells transfected with pcDNA3. 1 ( + )-aslL-8 was decreased. CONCLUSION: The eukaryotic expression vectors pcDNA3.1 ( + )-sslL-8 or pcDNA3, 1 ( + )-aslL-8 have been constructed successfully, which lays a base for further study on roles of IL-8 in ovarian cancer and other tumors.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第9期798-801,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 天津市自然科学基金项目(08JCYBJC06900) 武警医学院科学技术研究重点项目(WJZ2007-1) 博士科研启动金项目(WBS2007-6)
关键词 IL-8 正义/反义 真核表达载体 卵巢癌细胞 IL-8 sense or antisense eukaryotic expression vector ovarian carcinoma cells
  • 相关文献

参考文献8

  • 1Penson RT,Kronish K,Duan Z,et al.Cytokines IL-1beta,IL-2,IL-6,IL-8,MCP-1,GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxe[J].Int J Gynecol Cancer,2000,10(1):33-41.
  • 2Merritt WM,Lin YG,Spannuth WA.Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth[J].J Natl Cancer Inst,2008,100(5):359-372.
  • 3王越,杨洁,高燕,东莉洁,姚智.IL-6、IL-8上调卵巢癌细胞雄激素受体表达的作用分别依赖MAPK途径和Src活化[J].免疫学杂志,2008,24(4):424-429. 被引量:19
  • 4Wang Y,Yang J,Gao Y,et al.Reciprocal regulation of 5alpha-Dihydrotestosterone,Interleukin-6 and Interleukin-8 during proliferation of epithelial ovarian carcinoma[J].Cancer Biol Ther,2007 6(6):864-871.
  • 5Masuya D,Huang C,Liu D,et al.The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients[J].Cancer,2001,92(10):2628-2638.
  • 6Poszepczynska E,Martinvalet D,Bouloc A,et al.Erythrodermic cutaneous T-cell lymphoma with disseminated pustulosis.Production of high levels of interleukin-8 by tumor cells[J].Br J Dermatol,2001,144(5):1073-1079.
  • 7Abdollahi T,Robertson NM,Abdollahi A,et al.Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3[J].Cancer Res,2003,63(15):4521-4526.
  • 8王越,杨洁,高燕,牛文彦,姚智.卵巢癌细胞IL-6、IL-8及其受体表达的研究[J].免疫学杂志,2006,22(5):475-479. 被引量:16

二级参考文献28

  • 1王越,杨洁,高燕,牛文彦,姚智.DHT、IL-6和IL-8对卵巢癌细胞体外增殖的作用[J].中华微生物学和免疫学杂志,2006,26(2):115-120. 被引量:6
  • 2王越,杨洁,高燕,牛文彦,姚智.卵巢癌细胞IL-6、IL-8及其受体表达的研究[J].免疫学杂志,2006,22(5):475-479. 被引量:16
  • 3Penson RT,Kronish K,Duan Z,et al.Cytokines IL.1beta,IL.2,IL.6,IL.8,MCP.1,GM.CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel[J].Int J Gynecol Cancer,2000,10 (1):33-41.
  • 4Kryczek I,Grybos M,Karabon L,et al.IL.6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity[J].Br J Cancer,2000,82(3):621-628.
  • 5Ivarsson K,Runesson E,Sundfeldt K,et al.The chemotactic cytokine interleukin.8.a cyst fluid marker for malignant epithelial ovarian cancer?[J].Gynecol Oncol,1998,71(3):420-423.
  • 6Obata NH,Tamakoshi K,Shibata K,et al.Effects of interleukin.6 on in vitro cell attachment,migration and invasion of human ovarian carcinoma[J].Anticancer Res,1997,17(1A):337-342.
  • 7Xu L,Fidler IJ.Interleukin 8:an autocrine growth factor for human ovarian cancer[J].Oncol Res,2000,12 (2):97-106.
  • 8Abdollahi T,Robertson NM,Abdollahi A,et al.Identification of interleukin 8 as an inhibitor of tumor necrosis factorrelated apoptosis.inducing ligand.induced apoptosis in the ovarian carcinoma cell line OVCAR3[J].Cancer Res,2003,63(15):4 521-4 526.
  • 9Chan MM,Fong D,Soprano KJ,et al.Inhibition of growth and sensitization to cisplatin.mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents[J].J Cell Physiol,2003,194(1):63-70.
  • 10Duan Z,Feller AJ,Penson RT,et al.Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology:analysis of interleukin IL.6,IL.8,and monocyte chemotactic protein 1 in the paclitaxel.resistant phenotype[J].Clin Cancer Res,1999,5 (11):3 445-3 453.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部